Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM
Partner
Lundbeckfond Ventures - Copenhagen, Denmark
Associate Director, Global Production Planning & Inventory Control Job
Celgene Corporation - Basking Ridge, NJ, US
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Director, IT Global Operation Services, End-User Informatics Job
Celgene Corporation - Summit, NJ, US

More Jobs >>

Events

New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Enforcement, Litigation and Compliance Conference
Dec. 6-7 — Washington, DC
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
CHI's Summit for Clinical Ops Executives (Scope)
February 7-9 — Miami

More Events >>

Related Tags >> Novartis Ixiaro Vaccine FDA approval

Intercell News

Most Popular Intercell Story

Intercell scrambles after vax patch flunks PhII

July 8, 2010 — 7:08am ET | By John Carroll

Startled by the unexpected failure of a mid-stage trial of its vaccine adjuvant patch, Intercell AG is changing up the vaccine it used in the study along with the hemagglutinin inhibition assay used Read more...

Intercell Press Releases

Merck and Intercell Announce Termination of Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
Intercell Announces New Management Structure
Update on Phase II/III Clinical Trial of Investigational Staphylococcus aureus Vaccine, V710
Intercell Announces Next Steps of Development for Pseudomonas Vaccine
Intercell provides update on clinical trials for the patch-based Travelers' Diarrhea vaccine

Latest Headlines

Intercell recalls encephalitis vaccine batch
May 27, 2011
Intercell and Novartis collaborate on Pseudomonas vax
April 5, 2011
Intercell scrambles after vax patch flunks PhII
July 8, 2010
Panel recommends Intercell's new Japanese encephalitis jab
June 25, 2009
Novartis wins OK for new Japanese Encephalitis jab
April 1, 2009

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK